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Background: Gold nanoparticles are useful tools for biological applications due to their attractive physical and
chemical properties. Their applications can be further expanded when they are functionalized with biological
molecules. The biological molecules not only provide the interfaces for interactions between nanoparticles and
biological environment, but also contribute their biological functions to the nanoparticles. Therefore, we used
self-assembling protein nanoparticles (SAPNs) to encapsulate gold nanoparticles. The protein nanoparticles are
formed upon self-assembly of a protein chain that is composed of a pentameric coiled-coil domain at the
N-terminus and trimeric coiled-coil domain at the C-terminus. The self-assembling protein nanoparticles form a
central cavity of about 10 nm in size, which is ideal for the encapsulation of gold nanoparticles with similar sizes.
Results: We have used SAPNs to encapsulate several commercially available gold nanoparticles. The hydrodynamic
size and the surface coating of gold nanoparticles are two important factors influencing successful encapsulation
by the SAPNs. Gold nanoparticles with a hydrodynamic size of less than 15 nm can successfully be encapsulated.
Gold nanoparticles with citrate coating appear to have stronger interactions with the proteins, which can interfere
with the formation of regular protein nanoparticles. Upon encapsulation gold nanoparticles with polymer coating
interfere less strongly with the ability of the SAPNs to assemble into nanoparticles. Although the central cavity of
the SAPNs carries an overall charge, the electrostatic interaction appears to be less critical for the efficient
encapsulation of gold nanoparticles into the protein nanoparticles.
Conclusions: The SAPNs can be used to encapsulate gold nanoparticles. The SAPNs can be further functionalized
by engineering functional peptides or proteins to either their N- or C-termini. Therefore encapsulation of gold
nanoparticles into SAPNs can provide a useful platform to generate a multifunctional biodevices.Background
Due to their unique size-dependent properties, inorganic
nanoparticles and their applications in the life sciences
have been a topic of dramatically increasing interest over
the last several years [1,2]. Gold nanoparticles (GNPs)
are the most commonly used inorganic nanoparticles for
biological applications [2,3], because of their attractive
physical and chemical properties [4]. GNPs have been
mainly used for labeling and visualizing applications as
they can strongly absorb and scatter visible light. This is
because of their surface plasmon resonance [5]. GNPs
are often used as contrast agents for transmission* Correspondence: peter.burkhard@uconn.edu
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distribution, and reproduction in any mediumelectron microscopy and X-ray imaging because of their
ability to scatter electrons and X-rays efficiently [6].
GNPs generate heat when they absorb light, which
enables their potential in photo-thermal therapeutic
applications [7,8]. GNPs are also promising as drug and
gene delivery vehicles [9]. For example, they have been
used as nano-bullets for gene guns [10]. In addition,
GNPs are inert and relatively biocompatible [11]. They
can easily be synthesized and conjugated with biological
molecules in a straightforward manner [4].
The uses of GNPs in biological applications have
demonstrated the importance of the conjugation of
GNPs with biological molecules [12,13]. The biological
molecules not only provide the interfaces for interac-
tions between nanoparticles and biological environment,
but also contribute their biological functions, such as
tumor cell targeting [14], cell penetration [15], antibody-entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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biological molecules, such as DNA, can serve as plat-
form for assembly and organization of GNPs [1,17]. Due
to their well-defined surface chemistry [4], GNPs can be
modified and functionalized with a wide variety of bio-
logical molecules, such as peptides [18], proteins [19],
oligonucleotides [1,17], carbohydrates [20], and even
whole viral capsids [21-26]. Although several publica-
tions reported that GNPs with a defined number of
attached molecules per particle could be obtained using
sorting techniques [27,28], no protocols for controlling
the exact number of attached molecules per gold parti-
cles have yet been established [29,30]. The viral capsids
provide an ordered and controlled platform for conjuga-
tion with GNPs [31,32]. However, the relatively stringent
structure of the viral capsids limits their further functio-
nalization via fusion with functional peptides [33].
In this paper, we present the use of self-assembling
protein nanoparticles (SAPNs) [34,35] to encapsulate
GNPs. The design principle of the SAPNs was inspired
from the symmetrical structure of viral capsids. To
mimic icosahedral viral capsids, Raman et al. developed
a strategy to construct a nanoparticle based on the self-
assembling properties of coiled-coil oligomerization
domains [35]. We recombinantly expressed the P6c pro-
tein (Figure 1a), which has an N-terminal 36-amino-acid
pentameric domain from the slightly modified cartilage
oligomerization matrix protein linked by two glycine
residues to a 46-amino-acid de novo designed trimeric
domain. In our previous works [34], we found that theFigure 1 Computer models for the encapsulation of GNPs into SAPNs
protein. (c) Computer model of the T = 3 icosahedral SAPN formed by self
approximately 10 nm. The thickness of the protein shell is about 9 nm. Blu
The his-tag is not shown. (d) Computer model of the encapsulation of gold
Green: pentameric coiled-coil domain. The his-tag is not shown. The size o
center). (e) The zoom-in model of the side chains from arginine residues (R
central cavity, and they might have interactions with GNPs.majority of the SAPNs formed by the P6c proteins have
T = 3-like icosahedral structure, although the SAPNs are
composed of multiple species with different numbers of
co-assembled proteins. The T = 3-like icosahedral model
shows that 180 protein chains self-assemble into SAPNs
with a shell of about 9 nm and a central cavity of about
10 nm (Figure 1c). The environment in the central cavity
can easily be modified by site directed mutagenesis. For
instance, the SAPNs can have a positively charged (P6c
in Figure 1a) or negatively charged (P11c in Figure 1b)
central cavity. The central cavity is ideal to encapsulate
GNPs with similar size. Here we describe the ability of
SAPNs to encapsulate commercially available GNPs that
have different sizes and surface coatings. The SAPNs
have a regular structure and can easily be functionalized
by fusing functional peptides to the termini of the P6c
protein. Therefore, the SAPNs provide a promising tool
for the functionalization of GNPs.
Results
Encapsulation of citrate-coated GNPs by P6c SAPNs
GNPs of the three different sizes of 5, 10 and 15 nm
with citrate surface coating were used to test the encap-
sulation capability of the P6c SAPNs. Negatively stained
TEM images (Additional file 1: Figure S1a-c) revealed
that the thickness of the organic layer around the GNPs
was approximately 1 nm manifested by the uranyl acet-
ate staining as a bright ring around the GNPs. The 5 nm
GNPs had an average hydrodynamic size of 7.2 nm,
while the 10 nm GNPs had an average hydrodynamic. (a) The sequence of P6c protein. (b) The sequence of P11c
-assembling 180 P6c protein chains. The central cavity has a size of
e: trimeric coiled-coil domain. Green: pentameric coiled-coil domain.
nanoparticle by the P6c SAPN. Blue: trimeric coiled-coil domain.
f the gold nanoparticle is around 10 nm (golden-colored ball in the
61 in P6c). These side chains results in a highly positively charged
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ference between the acclaimed GNP sizes and measured
hydrodynamic sizes is attributed to the thickness of the
citrate layer and the adsorbed water layer.
The encapsulation results of the 5 nm GNPs are
shown in Figure 2. TEM images showed that the 5 nm
GNPs with citrate coating were not stable in the refold-
ing buffers of the SAPN, as they contained 75 mM or
150 mM NaCl. The majority of the 5 nm GNPs aggre-
gated before being encapsulated by the P6c SAPNs
(Figures 2a and b). TEM images also showed that few
5 nm GNPs were encapsulated by P6c SAPNs, which is
demonstrated in the insets of Figures 2a and b. The pro-
tein shells around the few encapsulated GNPs were
nearly spherical. The thickness of the organic layers
around the encapsulated GNPs was approximately 11
nm, which is close to the thickness of the protein shell
in the T = 3-like icosahedral model of the P6c SAPNs.
This suggests that the encapsulation of the 5 nm GNPs
did not disturb the formation of the P6c SAPNs in the
refolding buffers containing 75 mM and 150 mM NaCl,
although the encapsulation yields were rather low.
In order to avoid aggregation of the 5 nm GNPs, a
refolding buffer containing only 10 mM NaCl was used.
The 5 nm GNPs were shown to be stable in the refold-
ing buffer containing 10 mM NaCl. However, the protein
shells around the encapsulated GNPs became irregular
(Figure 2c), which implies that the integrity of the
P6c SAPNs was disturbed by the stronger interaction
between the protein and the GNPs in buffers with lower
ionic strength.
Figure 2d shows the light scattering results of the en-
capsulation samples in buffers with three different salt
concentrations. DLS results show that the average
hydrodynamic size of the sample prepared in 150 mM
NaCl buffer was larger than those prepared in 75 and
10 mM NaCl buffers. As the samples were mixtures of
free GNPs, empty P6c SAPNs, and the GNPs encap-
sulated by P6c SAPNs, light scattering will yield the
average hydrodynamic sizes of all the three kinds ofFigure 2 Encapsulation of 5 nm citrate-coated GNPs into P6c SAPNs.
(a) 20 mM HEPES pH 7.5, 150 mM NaCl, 5% Glycerol; (b) 20 mM HEPES pH
5% Glycerol. (d) DLS profiles for volume distribution of hydrodynamic sizesparticles. The larger average hydrodynamic size in
150 mM NaCl buffer might be due to the aggregation of
the GNPs and/or the larger P6c SAPNs [34].
The encapsulation results of the 10 nm citrate coated
GNPs are shown in Figure 3. There were no obvious
GNP aggregations observed in the refolding buffer con-
taining 10 mM HEPES pH 7.5, 75 mM NaCl, and 5%
glycerol. Therefore, the encapsulation experiment for the
10 nm GNPs was performed in the 75 mM salt buffer
using three different ratios of protein to GNPs. After
refolding, the samples were dialyzed in a buffer contain-
ing 20 mM HEPES pH 7.5, 150 mM NaCl, and 5% gly-
cerol. Figures 3a and b show that there were many
empty P6c SAPNs, which implies that there was an
excess of P6c protein compared to the concentration
of GNPs. Figures 3a and b also show that all GNPs
were encapsulated by the P6c SAPNs. The thickness
of the protein shells around the encapsulated GNPs
was approximately 9 nm, which is close to the theoret-
ical thickness of the protein shell in the T=3-like icosa-
hedral P6c SAPNs. The shapes of the protein shells
around GNPs were somewhat irregular, which could be
explained by the interactions between the protein chains
and the GNP surface.
Figure 3c shows the effect of using lower protein con-
centration during encapsulation. Although the shapes of
the protein shells was more spherical and regular, the
thickness of the protein shells around the encapsulated
GNPs in Figure 3c was approximately 4.5 nm, which
was much thinner than those shown in Figures 3a and b.
The difference in the thickness of the protein shells
could be due either to insufficient amount of protein for
the formation of complete protein shells or to the col-
lapse of the protein on the surface of GNPs.
DLS results (Figure 3d) show that the average hydro-
dynamic sizes of the encapsulated samples slightly
decreased with decreasing ratio of protein to GNPs.
When an excess of P6c was used (Figure 3d, black and
red line), the average hydrodynamic sizes are actually
the average of the empty SAPNs and encapsulatedTEM images of the encapsulation samples at three buffer conditions:
7.5, 75 mM NaCl, 5% Glycerol; (c) 20 mM HEPES pH 7.5, 10 mM NaCl,
of the encapsulation samples at the three buffer conditions.
Figure 3 Encapsulation of 10 nm citrate-coated GNPs into P6c SAPNs. TEM images of the encapsulation samples that have three different
ratios of P6c protein to GNPs, respectively: (a) The P6c protein concentration was 0.05 mg/ml (approximately 4 nmol/ml). The 10 nm GNPs
concentration was 4.7×10-4 nmol/ml (0.47 nM). (b) The P6c protein concentration was 0.05 mg/ml. The 10 nm GNPs concentration was 4.7×10-3
nmol/ml (4.7 nM). (c) The P6c protein concentration was 0.025 mg/ml. The 10 nm GNPs concentration was 4.7×10-3 nmol/ml (4.7 nM). The 10 nm
GNPs were first diluted in the refolding buffer containing 10 mM HEPES, 75 mM NaCl, 5% glycerol, pH 7.5. Then the denatured P6c protein was
refolded in the GNPs solutions using the quick refolding method. After protein refolding, all three samples were dialyzed in a buffer containing
20 mM HEPES, 150 mM NaCl, 5% Glycerol. (d) DLS profiles for volume distribution of hydrodynamic sizes of the encapsulation samples.
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insufficient amount of protein was used, the protein
shells around the encapsulated GNPs became thinner.
Therefore the average hydrodynamic size of the encap-
sulation sample with 0.025 mg/ml P6c and ~4.7×10-3
nmol/ml GNPs became smaller. There was a peak
around 11 nm (Figure 3d, blue line) present in the
encapsulation sample with an excess of GNPs, which is
close to the hydrodynamic size of free GNPs. The smal-
ler peak suggests that free GNPs were present in the
solution due to an excess of GNPs.
The encapsulation results of 15 nm GNPs are shown
in Figure 4. Two different ratios of protein to GNPs
were used for the encapsulation of 15 nm GNPs with
P6c. Figure 4a shows that an excess of P6c proteins was
used for encapsulation, as empty P6c SAPNs are visible
on the TEM image. The protein shells around the encap-
sulated GNPs had irregular shapes, and the thickness of
the protein shells was approximately 6.5 nm. It is pos-
sible that the 15 nm GNPs had strong interactions with
the protein chains, which caused the collapse of proteinFigure 4 Encapsulation of 15 nm citrate-coated GNPs into P6c SAPNs
ratios of P6c protein to GNPs, respectively: (a) The P6c protein concentratio
concentration was approximately 2.3×10-3 nmol/ml. (b) The P6c protein co
approximately 2.3×10-3 nmol/ml. The denatured P6c protein was refolded
refolding, all three samples were dialyzed in buffer containing 20 mM HEPE
of hydrodynamic sizes of the encapsulation samples.onto the gold surfaces. As shown by Figure 4b, an insuf-
ficient amount of P6c was used for encapsulation. The
protein shells around the GNPs were incomplete and
thinner, compared with the samples shown in Figure 4a.
TEM images also showed that the sample with too
low protein concentration had a tendency to aggregate
(Figure 4b). DLS results (Figure 4c) showed that the
average hydrodynamic size of the sample with insuffi-
cient amount of protein (0.025 mg/ml P6c) was larger
than that with excess protein (0.05 mg/ml P6c). The
increased hydrodynamic radius is probably due to the
aggregation. This can be observed in TEM images
(Figure 4b).
Encapsulation of PEG-coated GNPs by P6c SAPNs
PEG-coated GNPs of two gold core sizes of 5 and 10 nm
were purchased from Nanocs and used for encapsula-
tion. The TEM images of the PEG-coated GNPs with 1%
uranyl acetate staining are shown in Additional file 2:
Figure S2. The light aureole around the black dots (gold
cores) proves the presence of PEG layers coating on the. TEM images of the encapsulation samples that have two different
n was 0.05 mg/ml (approximately 4 nmol/ml). The 10 nm GNPs
ncentration was 0.025 mg/ml. The 10 nm GNPs concentration was
in the GNPs solutions using quick refolding method. After protein
S, 150 mM NaCl, 5% Glycerol. (c) DLS profiles for volume distribution
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polymer layers were not regular, the whole particle sizes
were considerably larger than the core sizes of the
GNPs. Additional file 2: Figure S2c shows the dynamic
light scattering profiles of the two PEG-coated GNPs.
The hydrodynamic size was 18.6 nm and 21.6 nm for
the PEG-coated GNPs with the gold core sizes of 5 nm
and 10 nm, respectively. The large hydrodynamic sizes
are mainly attributed to the PEG layers and a little to
the adsorbed water layer.
The encapsulation results for the two PEG-coated
GNPs with P6c are shown in Figure 5. All the GNPs
(dark dots) were located outside of the protein nanopar-
ticles, which shows that the PEG-coated GNPs were not
encapsulated into the P6c SAPNs. The failure of encap-
sulation might be due to their large hydrodynamic size.
DLS results (Figure 5c) showed similar profiles for both
of the encapsulation samples of the 5 nm and 10 nm
PEG-coated GNPs. However, light scattering cannot dis-
tinguish the PEG-coated GNPs from the P6c SAPNs,
since the hydrodynamic size of the PEG-coated GNPs is
close to the one of the P6c nanoparticles.
Encapsulation of polymer-coated GNPs with carboxyl
or amine surface functional groups by P6c SAPNs
The P6c SAPNs have a positively charged central cavity
due to its arginine residues (R61 in P6c) as shown in a
computer model (Figure 1c). Electrostatic interactions
between the central cavity and the surface charges from
GNPs might exist. Therefore GNPs with different surface
charges were tested for encapsulation. The polymer-
coated GNPs with carboxyl surface functional groups
were purchased from Ocean NanoTech, Inc. The GNPs
were coated with amphiphilic polymer bearing carboxyl
functional groups. The size of the inorganic core was
about 5 nm. The thickness of the organic layers was
about 4 nm, as shown in the negatively stained TEM
images (Additional file 3: Figure S3a). Dynamic light
scattering (Additional file 3: Figure S3c) showed that the
hydrodynamic size of the GNPs was 15 nm.Figure 5 Encapsulation of PEG-coated GNPs into P6c SAPNs. TEM ima
nanoparticles into P6c SAPNs: (a) 5 nm PEG-coated GNPs, (b) 10 nm PEG-c
SAPNs failed. (c) DLS profiles for volume distribution of hydrodynamic sizes
is 0.05 mg/ml for all samples.The polymer-coated GNPs with amine surface func-
tional groups were also purchased from Ocean Nano-
Tech, Inc. The GNPs were coated with amphiphilic
polymer and PEG coating. Their surface functional
group is amine. The size of the inorganic core was about
6 nm. The thickness of the organic layers was about
6 nm (Additional file 3: Figure S3b). Dynamic light scat-
tering (Additional file 3: Figure S3c) showed that the
hydrodynamic size of the GNPs was 19.6 nm.
The encapsulation results for the two types of GNPs
are shown in Figure 6. TEM images (Figure 6a) show
that most of the polymer-coated GNPs with carboxyl
functional groups were encapsulated into the P6c
SAPNs. TEM images also show that there were few
empty P6c SAPNs and free GNPs in the sample. The
total thickness of the protein layer and the organic layer
was approximately 15 nm. Therefore, the thickness of
the protein layer was approximately 10 nm. DLS results
show the encapsulation sample had an average hydro-
dynamic size of about 42 nm (Figure 6c, black line). The
polymer-coated GNPs with amine functional groups
failed to be encapsulated into the P6c SAPNs. TEM
images (Figure 6b) show that all the GNPs (dark dots)
were located outside of the SAPNs. The different encap-
sulation results between the two kinds of GNPs could
be attributed either to their different surface charges, to
their different sizes. But also other factors such as differ-
ent hydrophobicity could play a role. DLS results show
the encapsulation sample had an average hydrodynamic
size of about 33 nm (Figure 6c, red line). However, DLS
cannot resolve the size difference between the polymer-
coated GNPs and the SAPNs.
Encapsulation of GNPs by P11c SAPNs
The P6c protein has an arginine residue (R61 in P6c,
Figure 1a) next to its two-glycine linker, which results in
a positively charged central cavity within the P6c SAPN
after refolding. When a GNP is encapsulated into the
P6c SAPN, the residues around the two-glycine linker
are probably in contact with the surface of the GNPges of the encapsulation samples for the PEG-coated gold
oated GNPs. The encapsulation of PEG-coated GNPs into P6c
of the encapsulation samples. The P6c protein concentration
Figure 6 Encapsulation of polymer-coated GNPs into P6c SAPNs. TEM images of the encapsulation samples for (a) the polymer-coated
GNPs with surface carboxylic acid functional groups (GNPs with -COOH), and (b) the polymer-coated GNPs with surface amine functional groups
(GNPs with –NH2). (c) DLS profiles for volume distribution of hydrodynamic sizes of the encapsulation samples. The P6c protein concentration
is 0.05 mg/ml for all samples.
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might affect the encapsulation of GNPs. In order to
test the effect of the possible electrostatic interactions
between the cavity and the encapsulated GNP, the argin-
ine residue was mutated to a glutamic acid residue (E61
in P11c, Figure 1b). Therefore, P11c SAPNs presumably
have an overall negatively charged central cavity.
The P11c protein was tested for encapsulating the
10 nm citrate-coated GNPs using similar conditions as
for the P6c protein. TEM images (Figure 7) show that
the 10 nm citrate-coated GNPs were encapsulated by
P11c in both buffers containing 10 mM and 150 mM
NaCl. The thickness of the protein layer was approx-
imately 8–9 nm for both encapsulation samples.
Figure 7c shows the DLS results of the two encapsula-
tion samples. The main factor that contributed to the
difference of the DLS results is probably the different
sizes of the P11c SAPNs formed in the 10 mM and
150 mM NaCl buffer, since excess amount of empty
P11c SAPNs was observed in TEM images (Figure 7).
The P11c protein was also used to encapsulate the
polymer-coated GNPs with carboxyl functional groups.
TEM images (Figure 8) show that the polymer-coated
GNPs with carboxyl functional groups were encapsu-
lated into the P11c SAPNs in both buffers. The thickness
of the total organic layer was approximately 14–15 nm.Figure 7 Encapsulation of 10 nm citrate-coated GNPs into P11c SAPN
(a) 20 mM HEPES, 10 mM NaCl, 5% glycerol, pH 7.5; and (b) 20 mM HEPES,
is 0.05 mg/ml. (c) DLS profiles for volume distribution of hydrodynamic sizeTherefore, the thickness of the protein layer was ap-
proximately 9–10 nm, which is close to the theoretical
thickness of the protein shell in the T=3-like SAPN
model. Figure 8c shows the dynamic light scattering
results for the two samples. The encapsulation sample in
150 mM NaCl buffer has a large average hydrodynamic
size, which can be explained by aggregations in the
sample as shown in Figure 8b.
P11c was also used to encapsulate the polymer-coated
GNPs with amine functional groups. Figure 9 shows that
the GNPs were not located inside the SAPNs. The failure
of encapsulation of the polymer-coated GNPs with amine
functional groups could be due to their larger sizes.
Discussion
Our previous work [34] suggested that the majority of
the P6c SAPNs are T = 3-like icosahedral particles.
Therefore, there might be a size limit for GNPs to be
encapsulated. The encapsulation results for the citrate-
coated GNPs of three different sizes show that GNPs with
hydrodynamic size smaller than about 15 nm (citrate-
coated GNPs with 5 nm and 10 nm core sizes) can be
encapsulated, although there are aggregation problems
with the GNPs in the buffers containing high salt con-
centrations. The aggregation problem is likely due to
increased hydrophobic interactions driven by higher salts. TEM images of the encapsulation samples at two buffer conditions:
150 mM NaCl, 5% glycerol, pH 7.5. The P11c protein concentration
s of the encapsulation samples.
Figure 8 Encapsulation of polymer-coated GNPs bearing carboxyl functional groups into P11c SAPNs. TEM images of the encapsulation
samples at two buffer conditions: (a) 20 mM HEPES, 10 mM NaCl, 5% glycerol, pH 7.5; and (b) 20 mM HEPES, 150 mM NaCl, 5% glycerol, pH 7.5.
The P11c protein concentration is 0.05 mg/ml. (c) DLS profiles for volume distribution of hydrodynamic sizes of the encapsulation samples.
Yang and Burkhard Journal of Nanobiotechnology 2012, 10:42 Page 7 of 11
http://www.jnanobiotechnology.com/content/10/1/42concentration. Similarly, the polymer-coated GNPs with
carboxyl surface functional groups can be successfully
encapsulated into SAPNs, as this type of GNPs also has a
hydrodynamic size of 15 nm. On the contrary, the failures
in encapsulation of the PEG-coated GNPs (Figure 5) and
the polymer-coated GNPs with amine functional groups
(Figure 6b) can be attributed to their large hydrodynamic
sizes; the three types of GNPs have average hydrodynamic
sizes ranging from 18.6 to 21.6 nm.
It is ideal for SAPNs to maintain their original ico-
sahedral T = 3-like structure after encapsulation of
GNPs. Comparison of the encapsulation samples from
the three citrate-coated GNPs indicated that the protein
shells coated on larger GNPs are thinner and irregular
(Figure 2, 3, 4). The thickness of the protein shell was
estimated by comparing the difference between the aver-
age size of the SANPs which encapsulate GNPs
(GNP@SAPN) and the free GNPs (Figure 10). Although
the sizes of GNPs vary, the average sizes of GNP@SAPN
change only relatively little (around 30 nm). The average
thickness of peptide shells decreased from approximately
11 nm for the 5 nm GNPs, to approximately 9 nm for
the 10 nm GNPs, and to only about 6.5 nm for the
15 nm GNPs. The differences in the morphology and
thickness of the protein shells imply that the protein
chains may to some degree collapse on the surface ofFigure 9 Encapsulation of polymer-coated GNPs bearing amine funct
samples at two buffer conditions: (a) 20 mM HEPES, 10 mM NaCl, 5% glyce
The P11c protein concentration is 0.05 mg/ml. (c) DLS profiles for volume dthe larger GNPs. This collapsing might be due to strong
electrostatic interactions between the proteins and the
gold surface [36-38]. Based on computer models, the
P6c SAPNs have a positively charged central cavity
contributed by arginine residues (R61 in P6c, Figure 1).
The arginine residues might have electrostatic interac-
tions with citrate on the GNP surface. Therefore, P11c
with a glutamic acid residue at position 61 was used to
examine the role of the charge of this residue during en-
capsulation. However, encapsulation results of P11c and
P6c with the 10 nm citrate-coated GNPs were well com-
parable in both buffers with high and with low salt con-
centrations (10 or 150 mM). This suggests that complex
interactions between the protein and citrate-coated
GNPs exist and that the protein might to some degree
collapse on the surface of GNPs.
To alleviate the strong interactions between proteins
and gold surfaces, GNPs with PEG or amphiphilic poly-
mer coatings were tested. Compared with the citrate-
coated GNPs, the encapsulation samples from the
polymer-coated GNPs with surface carboxylic acid func-
tional groups (Figure 6a) possessed more regular protein
shells coating the GNPs. The GNPs encapsulating
SAPNs became larger than the empty SAPNs (Figure 11).
Our previous work [34] shows that the SAPNs can form
different species other than the majority of T = 3-likeional groups into P11c SAPNs. TEM images of the encapsulation
rol, pH 7.5; and (b) 20 mM HEPES, 150 mM NaCl, 5% glycerol, pH 7.5.
istribution of hydrodynamic sizes of the encapsulation samples.
Figure 10 Comparison of the encapsulation samples from the 5, 10 and 15 nm citrate-coated GNPs. The sizes of the free gold
nanoparticles (GNP, red), empty protein nanoparticles (SAPN, green), and gold nanoparticles encapsulated by protein nanoparticles (GNP@SAPN,
blue) measured from the TEM images of the encapsulation samples from (a) the 5 nm citrate-coated GNPs (Figure 2a), (b) the 10 nm
citrate-coated GNPs (Figure 3b), and (c) the 15 nm citrate-coated GNPs (Figure 4a), respectively. The sizes were obtained by the program
ImageJ, and presented as box-and-whisker plots (the bottom and top of the box are the lower and upper quartiles, the band near the middle
of the box is the median, and the ends of whiskers represent the minimum and maximum sizes).
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might be due to the formation of larger species, as the
hydrodynamic size of the GNPs (~15 nm) is larger than
the theoretical size (~10 nm) of the central cavity of T =
3-like SAPNs. The changes in sizes might imply that
SAPNs have a certain degree of tolerance for encap-
sulating GNPs slightly larger than their central cavity.
However, there is a limit for the tolerance, as GNPs hav-
ing average hydrodynamic sizes ranging from 18.6 to
21.6 nm failed to be encapsulated. The thickness of
the protein layers coated on the GNPs was estimated as
approximately 10 nm (Figure 11), which is close to the
theoretical thickness of the protein shells in the model
of T = 3-like SAPNs. The morphology of the protein
shells suggests that the protein chains didn’t collapse on
the surface of the polymer-coated GNPs. Without the
collapse of proteins onto the gold surface, the positively
charged arginine residues at position 61 might become
more important for possible electrostatic interactions,
as residues at positions far from the two-glycine linker
will not have direct contacts with GNPs. However, the
P11c protein again yields similar encapsulation results for
the polymer-coated GNPs with surface carboxylic acid
functional groups (Figure 8). Therefore, the electrostaticFigure 11 Analysis of the encapsulation samples from the polymer-co
gold nanoparticles (GNP, red), empty protein nanoparticles (SAPN, green), a
(GNP@SAPN, blue). (b) The sizes of the free GNPs, empty SAPNs and GNP@
measured by the program ImageJ, presented as box-and-whisker plots.interaction between GNPs and the central cavity may not
play a vital role during encapsulation.
Conclusions
The success of encapsulation of GNPs into SAPNs
allows further functionalization by fusing functional pep-
tides to the nanoparticle-forming protein chains. The
SAPNs can present the functional peptides on its surface
in an ordered and repetitive ways, when the functional
peptides were fused to the termini of the protein chains.
Methods
Protein Expression and Purification
The modified pPEP-T vector [39] was kindly provided by
the M. E. Müller Institute, Basel, Switzerland. The genes
encoding P6c and P11c protein were placed between
NcoI and EcoRI restriction sites. The plasmids were then
transformed into the Escherichia Coli strain BL21(DE3)
pLysS expression cells (Novagen, Madison, WI, USA).
The bacteria were incubated at 37°C in Luria Broth (LB)
medium in the presence of 200 mg/ml ampicillin and
30 mg/ml chloramphenicol. Expression was induced by
adding 1 mM isopropyl β-D-thiogalactopyranoside. After
3 hours of expression, the bacteria were collected byated GNPs. (a) Light scattering profiles of the free polymer-coated
nd gold nanoparticles encapsulated by protein nanoparticles
SAPN from the TEM images of the encapsulation samples were
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pellet was resuspended and lysed in a lysis buffer
(9 M urea, 100 mM NaH2PO4, 10 mM Tris, 10 mM β-
mercaptoethanol, and pH 8.0) by sonication. The cell
debris was removed by centrifugation at 305000 g
for 45 min. The supernatant was then incubated with
Ni-NTA Agarose beads (Qiagen, Valencia, CA, USA)
overnight and then loaded into a column. The protein
contaminants were removed by washing the column
sequentially with pH buffers 6.3, 5.9 and 5.0, which con-
tain 9 M urea, 100 mM NaH2PO4, 20 mM sodium citrate,
10 mM imidazole and 10 mM β-mercaptoethanol. The
P6c proteins were then eluted by the elution buffer con-
taining 9 M urea, 100 mM NaH2PO4, 10 mM Tris,
500 mM imidazole, 10 mM β-mercaptoethanol and
pH 8.0. The purity of the P6c proteins was verified by
sodium dodecyl sulfate polyacrylamide gel electrophoresis.
Protein refolding procedure
The P6c protein was first denatured in a urea-containing
buffer (9 M urea, 20 mM HEPES, 150 mM NaCl, 5%
Glycerol, pH 7.5), and then concentrated to 1 mg/ml.
The protein was refolded by adding it drop wise to
the refolding buffer (20 mM HEPES, 150 mM NaCl,
5% Glycerol, pH 7.5), until the protein concentration
reached a concentration of 0.05 mg/ml. The samples
were then dialyzed overnight in the refolding buffer to
remove the remaining urea.
GNPs
The citrated-coated gold nanoparticles of the three gold
core sizes of 5, 10 and 15 nm, respectively, were pur-
chased from Nanocs Inc., New York, USA. The stock
concentrations of the 5, 10 and 15 nm citrate-coated
gold nanoparticles were approximately 0.083, 0.0095 and
0.0023 nmole/ml, respectively.
The PEG-coated gold nanoparticles with two gold core
sizes of 5 and 10 nm were purchased from Nanocs Inc.,
New York, USA. The stock concentrations of the 5 and
10 nm PEG-coated gold nanoparticles were approxi-
mately 0.083 and 0.0095 nmole/ml, respectively.
The polymer-coated gold nanoparticles with carboxyl
or amine surface functional groups were purchased from
Ocean NanoTech Inc., AR, USA. Both polymer-coated
gold nanoparticle had 5 nm gold cores. The gold nano-
particles with carboxylic acid groups were coated with
dodecanethiol and a monolayer of amphiphilic polymer.
The zeta potential of these gold nanoparticles is −30 mV
to −50 mV (provided by the supplier). The concentra-
tion of the gold nanoparticles with carboxylic acid
groups was about 5 mg/ml, which gives a concentra-
tion of approximately 6.7 nmole/ml. The gold nanoparti-
cles with amine groups were coated with amphiphilic
polymer and PEG. The zeta potential of these goldnanoparticles is −10 mV to +10 mV (provided by the
supplier). The concentration of the gold nanoparticles
with amine groups was about 1 mg/ml, which gives a
concentration of approximately 1.3 nmole/ml.
Encapsulation of citrate-coated gold nanoparticles
by P6c SAPNs
The P6c proteins were first denatured in the denaturing
buffer (9 M urea, 20 mM HEPES pH 7.5, 150 mM NaCl,
5% glycerol). Then the denatured proteins were con-
centrated to about 1 mg/ml using the Amicon centrifuge
filter (5000 MWCO, Millipore, MA, USA).
The 5 nm citrate-coated nanoparticles were diluted in
the refolding buffer to a concentration of approximately
0.0047 nmole/ml. Three different refolding buffers were
used for dilution of gold nanoparticles. The refolding
buffers were composed of 20 mM HEPES pH 7.5, 5%
glycerol, and 10, 75, and 150 mM NaCl, respectively.
Then, the denatured P6c protein solution (~1 mg/ml)
was added drop wise to the GNP-refolding buffer until
the protein concentration reached a concentration of
0.05 mg/ml (3.96 nmole/ml) in the final protein-GNP
solution. The protein-GNP solution was then dialyzed
overnight against the buffer (20 mM HEPES pH 7.5,
150 mM NaCl, 5% glycerol) to remove the remaining urea.
The encapsulation procedures for the 10 nm citrate-
coated gold nanoparticles were similar to that for the
5 nm citrate-coated gold nanoparticles. The 10 nm
citrate-coated gold nanoparticles were first diluted in the
refolding buffer containing 10 mM HEPES pH 7.5,
75 mM NaCl, and 5% glycerol. Then, the denatured P6c
protein solution (~1 mg/ml) was added drop wise to the
GNP-refolding buffer until the protein concentration
reached a concentration of 0.05 mg/ml (3.96 nmole/ml)
in the final protein-GNP solution. The protein-GNP
solution was then dialyzed overnight against the buffer
(20 mM HEPES pH 7.5, 150 mM NaCl, 5% glycerol) to
remove the remaining urea. Three different molar ratios
of gold nanoparticles to proteins were used for the
encapsulation: (a) The P6c protein concentration was
0.05 mg/ml (approximately 4 nmol/ml). The 10 nm
GNPs concentration was 4.7×10-4 nmol/ml. (b) The P6c
protein concentration was 0.05 mg/ml. The 10 nm GNPs
concentration was 4.7×10-3 nmol/ml. (c) The P6c pro-
tein concentration was 0.025 mg/ml. The 10 nm GNPs
concentration was 4.7×10-3 nmol/ml.
The encapsulation procedures for the 15 nm citrate-
coated gold nanoparticles were also similar to that for
the 5 nm citrate-coated gold nanoparticles. The 15 nm
citrate-coated gold nanoparticles were first dissolved in
the refolding buffer containing 10 mM HEPES pH 7.5,
75 mM NaCl, and 5% glycerol. Then, the denatured P6c
protein solution (~1 mg/ml) was added drop wise to the
GNP-refolding buffer, until the protein concentration
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in the final protein-GNP solution. The protein-GNP
solution was then dialyzed overnight against the buffer
(20 mM HEPES pH 7.5, 150 mM NaCl, 5% glycerol) to
remove the remaining urea. Two different molar ratios
of gold nanoparticles to proteins were used for the
encapsulation: (a) The P6c protein concentration was
0.05 mg/ml (approximately 4 nmol/ml). The 10 nm
GNPs concentration was approximately 2.3×10-3 nmol/ml.
(b) The P6c protein concentration was 0.025 mg/ml.
The 10 nm GNPs concentration was approximately
2.3×10-3 nmol/ml.
Encapsulation of PEG-coated gold nanoparticles
by P6c SAPNs
The PEG-coated gold nanoparticles were first diluted in
the refolding buffer containing 10 mM HEPES pH 7.5,
75 mM NaCl, and 5% glycerol to a concentration of
approximately 0.0047 nmole/ml. Then, the denatured
P6c protein solution (~1 mg/ml) was added drop wise to
the GNP-refolding buffer until the protein concentration
reached 0.05 mg/ml (3.96 nmole/ml) in the final protein-
GNP solution. The protein-GNP solution was then dia-
lyzed overnight against the buffer (20 mM HEPES pH
7.5, 150 mM NaCl, 5% glycerol) to remove the remain-
ing urea.
Encapsulation of polymer-coated gold nanoparticles
with carboxyl or amine surface functional groups
by P6c SAPNs
The polymer-coated gold nanoparticles were diluted
to approximately 0.01 nmole/ml in the refolding buffer
(20 mM HEPES pH 7.5, 150 mM NaCl, 5% glycerol).
Then, the denatured P6c protein solution (~1 mg/ml)
was added drop wise to the GNP-refolding buffer, until
the protein concentration reached a concentration of
0.05 mg/ml (3.96 nmole/ml) in the final protein-GNP
solution. The protein-GNP solution was then dialyzed
overnight against the buffer (20 mM HEPES pH 7.5,
150 mM NaCl, 5% glycerol) to remove the remaining urea.
Encapsulation of gold nanoparticles by P11c SAPNs
The encapsulation procedures for gold nanoparticles by
the P11c SAPNs were similar to the procedures for the
P6c SAPNs. P11c SAPNs were used for the encapsula-
tion of all three kinds of gold nanoparticles mentioned
above. The concentration of the P11c proteins was
kept as 0.05 mg/ml for all the encapsulation samples.
In the final encapsulation samples, approximately 0.0047
nmole/ml of the citrate-coated gold nanoparticles were
used. The concentrations of the polymer-coated gold
nanoparticles were also approximately 0.01 nmole/ml
in their encapsulation samples.Dynamic light scattering
The hydrodynamic diameter was determined with a
Malvern Zetasizer Nano S equipped with a 633 nm laser.
Hellma Quartz cuvettes with a 3 mm light path and
centre 9.65 mm were used (Cat. No. 105.251.005-QS).
The measurements were performed at 20°C using 80 μl
samples. All the samples were filtered once using 0.1 μm
Millex-VV filter (Millipore, MA, USA) before measure-
ment. The volume-average hydrodynamic sizes were
reported by the Malvern DTS software, version 6.01.Transmission Electron Microscopy
A drop of 5 μl sample was placed on a 400 mesh copper
grid coated with Formvar/carbon film (Electron Micros-
copy Sciences, PA, USA) for 1 min. The grid was washed
sequentially by three drops of 5 μl distilled water. Then
the sample was negatively stained with a drop of 5 μl 1%
uranyl acetate (SPI Supplies, PA, USA) for 1 min. Excess
stain solution was removed by Whatman filter paper,
before the grid was slowly dried at room temperature.
Electron micrographs were taken with an FEI Tecnai
T12 transmission electron microscope at an accelerating
voltage of 80 kV.
The TEM images were first inspected with Photoshop
CS4 (Adobe, San Jose, CA). The particles were selected
and filled manually using the selection tools in Photo-
shop CS4, omitting the very small particles or back-
ground (area less than 50 nm2) and large aggregates
(area larger than 5000 nm2). Image analysis was then
performed with the public domain software ImageJ [40].
Then, the Feret diameter obtained by ImageJ was used
to describe the size of the particles.Additional files
Additional file 1: Figure S1. Citrate-coated GNPs. TEM images of the
citrate-coated GNPs with 1% uranyl acetate staining: (a) 5 nm GNPs,
(b) 10 nm GNPs, and (c) 15 nm GNPs. The thickness of the organic layer
is approximately 1 nm. (d) DLS profiles of the 5 nm and 10 nm GNPs
with citrate coating.
Additional file 2: Figure S2. PEG-coated GNPs. TEM images of the PEG-
coated GNPs with 1% uranyl acetate staining: (a) PEG-coated GNPs with
core size of 5 nm, (b) PEG-coated GNPs with core size of 10 nm. PEG-
coated GNPs are too large to be encapsulated. (c) DLS profiles of the
PEG-coated GNPs with core size of 5 nm and 10 nm respectively.
Additional file 3: Figure S3. Polymer-coated GNPs. TEM images of the
polymer-coated GNPs with 1% uranyl acetate staining: of (a) the gold
nanoparticles with surface carboxylic acid functional groups, and (b) the
gold nanoparticles with surface amine functional groups. (c) DLS profiles
of the polymer-coated GNPs with surface carboxylic acid functional
groups, and the polymer-coated GNPs with surface amine functional
groups, respectively.Competing interests
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